Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Top Life Sciences Consultancies in the USA: Choosing the Right Partner

Aug 29, 2025

Understanding the Importance of Life Sciences Consultancies

The life sciences sector is a complex and rapidly evolving industry that includes pharmaceuticals, biotechnology, medical devices, and more. Companies within this field often require specialized expertise to navigate regulatory challenges, drive innovation, and enhance operational efficiency. This is where life sciences consultancies play a crucial role. Choosing the right partner can significantly influence a company's success and growth trajectory.

Life sciences consultancies offer a range of services, including regulatory advice, market access strategies, clinical trial management, and technological innovation. Partnering with an experienced consultancy can provide companies with the insights needed to make informed decisions, optimize processes, and maintain compliance with industry standards.

scientists meeting

Key Considerations When Choosing a Consultancy

Expertise and Experience

When selecting a life sciences consultancy, one of the primary factors to consider is the firm's expertise and experience in your specific area of interest. Whether it's biotechnology, pharmaceuticals, or medical devices, having a partner with deep industry knowledge is invaluable. Look for consultancies that have a proven track record of success and a portfolio of projects relevant to your needs.

Range of Services

A comprehensive service offering is another critical attribute of a top consultancy. The best partners provide end-to-end solutions that cover everything from research and development to commercialization. Evaluate whether the consultancy provides the specific services you require and has the capability to support your company through various stages of growth.

consulting services

Top Life Sciences Consultancies in the USA

The USA is home to several leading life sciences consultancies renowned for their expertise and comprehensive service offerings. Here are some of the top firms in the industry:

  • IQVIA: Known for its data-driven insights and innovative solutions, IQVIA offers services across clinical development, technology solutions, and commercial effectiveness.
  • Deloitte Life Sciences: With a focus on strategy, operations, and digital transformation, Deloitte helps companies navigate the complexities of the life sciences landscape.
  • Accenture Life Sciences: Accenture combines industry knowledge with technology expertise to deliver integrated solutions for R&D, supply chain management, and patient engagement.
consultancy team

Evaluating Consultancy Partnerships

Cultural Fit

While expertise and service offerings are crucial, the cultural fit between your company and the consultancy should not be overlooked. A strong partnership is built on mutual understanding and aligned values. Ensure that the consultancy's approach aligns with your company's culture and business objectives.

Client Testimonials and Case Studies

Reviewing client testimonials and case studies can provide valuable insights into a consultancy's capabilities and client satisfaction levels. These resources can highlight how the consultancy has successfully addressed similar challenges faced by other companies in the life sciences sector.

Ultimately, choosing the right life sciences consultancy is about finding a partner that not only understands your industry's intricacies but also shares your vision for innovation and growth. By carefully evaluating potential partners based on expertise, services, cultural fit, and client feedback, you can select a consultancy that will drive your company towards greater success in the competitive landscape of life sciences.